31 December 2021 : Clinical Research
A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing
Dumitru Cristinel Badiu1B, Gabriel Cristian Popescu1F, Anca Zgura2A*, Adriana Mercan Stanciu3F, Mihai Daniel Dodot3F, Claudia Mehedintu4C, Letitia Toma3E, Simu Razvan3B, Xenia Bacinschi2D, Bogdan Haineala5ADOI: 10.12659/MSM.935075
Med Sci Monit 2021; 27:e935075
Table 2 Evolution of TSH, fT3, and fT4 in patients with euthyroidism and dysthyroidism after COVID-19 infection.
| Baseline | One month | P value | 3 Months | P value | ||
|---|---|---|---|---|---|---|
| TSH (μUI/mL) | Euthyroidism | 3.87±1.16 | 2.19±1.12 | 2.28±0.69 | 0.4 | |
| Hypothyroidism | 2.14±0.81 | 1.56 ±0.7 | na* | 2.12±0.43 | na* | |
| Hyperthyroidism | 3.27±1.03 | 2.67 ±1.14 | na* | 2.81±0.92 | na* | |
| fT3 (pg/ml) | Euthyroidism | 2.11±1.62 | 1.71±0.46 | 1.92±0.34 | 0.3 | |
| Hypothyroidism | 3.91±0.62 | 3.12±0.74 | na* | 3.44±0.68 | na* | |
| Hyperthyroidism | 2.57±1.31 | 2.09±0.45 | na* | 2.24±0.18 | na* | |
| fT4 (pmol/l) | Euthyroidism | 15.92±3.53 | 9.22±2.18 | 11.57±2.91 | 0.05 | |
| Hypothyroidism | 18.13±6.22 | 13.48±3.53 | na* | 15.54±4.45 | na* | |
| Hyperthyroidism | 16.46±3.13 | 12.17±2.95 | na* | 14.88±2.79 | na* | |
| * na – statistical analysis was not performed due to the low number of patients (2 patients with hyperthyroidism and 5 patients with hypothyroidism. | ||||||